Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One.

Alessandra Salerno1, Francesca Seghetti1, Jessica Caciolla1

  • 1Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.

Summary

Researchers are exploring multifunctional Proteolysis Targeting Chimeras (PROTACs) by combining degradation with other therapeutic strategies. This approach aims to enhance efficacy, reduce side effects, and target previously undruggable proteins.